Trial intelligence / Profile preview

Aspirin and Esomeprazole in Barrett's Esophagus

NCT00474903Phase 2Completed

Sponsor
National Cancer Institute
Start
Apr 2007
Primary completion
Mar 2011
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of aspirin in esophageal cancer, sponsored by National Cancer Institute. Started Apr 2007; status: completed.

02

Drugs

aspirin
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on NCT00474903.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00474903.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call